{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:08:54Z","timestamp":1785733734896,"version":"3.56.0"},"reference-count":57,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.01898","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T04:45:20Z","timestamp":1506401120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design"],"prefix":"10.3389","volume":"8","author":[{"given":"Zenglei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"234r","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/irv.12285","article-title":"Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins","volume":"8","author":"Blanchfield","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.vaccine.2015.12.062","article-title":"A highly immunogenic vaccine against A\/H7N9 influenza virus","volume":"34","author":"Cao","year":"","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cellimm.2016.04.004","article-title":"RIG-I ligand enhances the immunogenicity of recombinant H7HA protein","author":"Cao","year":"","journal-title":"Cell. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1128\/JVI.00100-14","article-title":"Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0120793","DOI":"10.1371\/journal.pone.0120793","article-title":"Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets","volume":"10","author":"Chia","year":"2015","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1016\/j.vaccine.2014.04.060","article-title":"Potency of an inactivated influenza vaccine prepared from A\/duck\/Mongolia\/119\/2008 (H7N9) against the challenge with A\/Anhui\/1\/2013 (H7N9)","volume":"32","author":"Chu","year":"2014","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"Cox","year":"2009","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/mt.2016.23","article-title":"H7N9 live attenuated influenza vaccine is highly immunogenic, prevents virus replication, and protects against severe bronchopneumonia in ferrets","volume":"24","author":"de Jonge","year":"2016","journal-title":"Mol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e99322","DOI":"10.1371\/journal.pone.0099322","article-title":"Response of mice and ferrets to a monovalent influenza A (H7N9) split vaccine","volume":"9","author":"Duan","year":"2014","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e23085","DOI":"10.1371\/journal.pone.0023085","article-title":"Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities","volume":"6","author":"Griffin","year":"2011","journal-title":"PLoS ONE"},{"key":"B17","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2013United States, 2013-2014","volume":"62","author":"Grohskopf","year":"2013","journal-title":"MMWR Recomm. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1099\/jgv.0.000365","article-title":"Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines","volume":"97","author":"He","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.virol.2016.10.027","article-title":"Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model","volume":"500","author":"Isakova-Sivak","year":"2017","journal-title":"Virology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.15585\/mmwr.mm6609e2","article-title":"Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic - China, October 2016-February 2017","volume":"66","author":"Iuliano","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01202-17","article-title":"Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies","author":"Kamal","year":"2017","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11233","DOI":"10.1038\/srep11233","article-title":"A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals","volume":"5","author":"Kong","year":"2015","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/infdis\/jiu528","article-title":"A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model","volume":"211","author":"Kreijtz","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jinf.2017.04.002","article-title":"Evolving HA and PB2 genes of influenza A (H7N9) viruses in the fifth wave - Increasing threat to both birds and humans?","volume":"75","author":"Li","year":"2017","journal-title":"J. Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1128\/JVI.00031-15JVI.00031-15","article-title":"Newcastle disease virus-vectored H7 and H5 live vaccines protect chickens from challenge with H7N9 or H5N1 avian influenza viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1080\/21645515.2015.1052197","article-title":"H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance","volume":"11","author":"Liu","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","article-title":"Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/infdis\/jiw414","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults","volume":"214","author":"Madan","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Mulligan","year":"2014","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.vaccine.2016.03.037","article-title":"Analysis of the immunogenicity and bioactivities of a split influenza A\/H7N9 vaccine mixed with MF59 adjuvant in BALB\/c mice","volume":"34","author":"Ou","year":"2016","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.04.003","article-title":"Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates","volume":"107","author":"Pan","year":"2014","journal-title":"Antiviral Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1073\/pnas.0602566103","article-title":"Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease","volume":"103","author":"Park","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS ONE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.antiviral.2014.06.017","article-title":"Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes","volume":"109","author":"Prabakaran","year":"2014","journal-title":"Antiviral Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1016\/j.vaccine.2011.06.068","article-title":"Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes","volume":"29","author":"Pushko","year":"2011","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.vaccine.2015.07.026","article-title":"Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus","volume":"33","author":"Pushko","year":"2015","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/vim.2015.0103","article-title":"Inactivated antigen of the H7N9 influenza virus protects mice from its lethal infection","volume":"29","author":"Seo","year":"2016","journal-title":"Viral Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0150678","DOI":"10.1371\/journal.pone.0150678","article-title":"Immunopotentiation of different adjuvants on humoral and cellular immune responses induced by HA1-2 subunit vaccines of H7N9 influenza in mice","volume":"11","author":"Song","year":"2016","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12896-015-0195-z","article-title":"An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin","volume":"15","author":"Song","year":"2015","journal-title":"BMC Biotechnol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"key":"B46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00705-014-2314-x","article-title":"Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection","volume":"160","author":"To","year":"2015","journal-title":"Arch. Virol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41598-017-01372-5","article-title":"A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines","volume":"7","author":"Wada","year":"2017","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2017.03.029","article-title":"A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice","volume":"143","author":"Wang","year":"2017","journal-title":"Antiviral Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0113963","DOI":"10.1371\/journal.pone.0113963","article-title":"Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs","volume":"10","author":"Wodal","year":"2015","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1016\/j.vaccine.2014.06.016","article-title":"A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets","volume":"32","author":"Wong","year":"2014","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0157287","DOI":"10.1371\/journal.pone.0157287","article-title":"In vitro and in vivo attenuation of Vesicular Stomatitis Virus (VSV) by phosphoprotein deletion","volume":"11","author":"Wongthida","year":"2016","journal-title":"PLoS ONE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1016\/j.vaccine.2014.06.043","article-title":"Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1016\/j.vaccine.2017.06.044","article-title":"Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: a phase I\/II, prospective, randomized, open-label trial","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jfma.2017.02.011","article-title":"Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, (2017)","volume":"116","author":"Yang","year":"2017","journal-title":"J. Formos. Med. Assoc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0123659","DOI":"10.1371\/journal.pone.0123659","article-title":"Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jinf.2017.04.001","article-title":"Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China","volume":"75","author":"Zhang","year":"2017","journal-title":"J. Infect."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T04:45:24Z","timestamp":1506401124000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.01898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2017.01898"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.01898","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]},"article-number":"1898"}}